Is Ambrx Biopharma Inc. (AMAM) a Buy, Sell, or Hold?
NYSE : AMAM
Ambrx Biopharma Inc. — Competitors
$28 USD
$0.02 (0.07%)
- Volume
- 1.42M
- Average Volume
- 2M
- Market Capitalization
- $1.77B
- P/E Ratio
- -13.86
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $28.15
- Year Low
- $6.55
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $5.44
AMAM vs. The Competition
| Properties | AMAM | BIESF | BLU | DICE |
|---|---|---|---|---|
| Market Cap | $1.77B | $1.6B | $1.87B | $2.27B |
| Shares Outstanding | $63.29M | $49.99M | $126.81M | $47.76M |
| P/E Ratio | -13.86 | 48.06 | -22.34 | -22.97 |
| EPS | -2.02 | 0.67 | -0.66 | -2.07 |
| Day Low | 27.98 | 32 | 14.74 | 47.46 |
| Day High | 28 | 32 | 14.75 | 47.83 |
| Year Low | 6.55 | 30.48 | 6.38 | 15.08 |
| Year High | 28.15 | 32 | 14.76 | 47.9 |
| Average Price 50 | 25.3258 | 32 | 14.3998 | 42.2608 |
| Average Price 200 | 16.44507 | 30.9816 | 10.1143 | 34.23555 |
| Volume | 1.42M | 100 | 2.84M | 4.33M |
| Average Volume | - | - | - | - |